下載本文檔
版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領
文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html Guanylate HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html CyclaseGuanylate cyclase (guanylyl cyclase, GC), which catalyzes the formation of cGMP from GTP, exists in
2、 both the soluble and particulatefractions of cells. Guanylyl cyclases signal via the production of the second messenger cGMP.The GC family consists of particulate GC (pGC) and a nitric oxide-activated soluble GC (sGC). Seven pGC isoforms have yet beenfound (pGC-A to pGC-G). pGCs are activated by bi
3、nding of peptide ligands to their extracellular domains. sGC is a receptor forendogenous and exogenous nitric oxide and is activated several-fold upon its binding, constituting a core enzyme in the nitricoxide signal transduction pathway. cGMP generated by sGC is an important second messenger that r
4、egulates activity of severalenzymes triggering such important physiologic reactions as vasodilation, smooth muscle relaxation and platelet aggregation.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html Guanylate HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HY
5、PERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html Cyclase HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HYPERLINK https:/www.MedChemE/Targets/
6、Guanylate Cyclase.html Agonists HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html & HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html HYPERLINK https:/www.MedChemE/Targets/Guanylate Cyclase.html Activators HYPERLINK h
7、ttps:/www.MedChemE/BM121307.html (4-Acetamidocyclohexyl) HYPERLINK https:/www.MedChemE/BM121307.html HYPERLINK https:/www.MedChemE/BM121307.html nitrate(BM121307) Cat. No.: HY-100295 HYPERLINK https:/www.MedChemE/rac-bi-703704.html (Rac)-BI HYPERLINK https:/www.MedChemE/rac-bi-703704.html HYPERLINK
8、https:/www.MedChemE/rac-bi-703704.html 703704Cat. No.: HY-117962(4-Acetamidocyclohexyl) nitrate (BM121307) is aguanylate cyclase activator.(Rac)-BI 703704 is a potent soluble guanylylcyclase (sGC) activator. (Rac)-BI 703704 reducesprogression of renal damage in the ZSF1 rat, andhighlight the potenti
9、al of sGC activation as aneffective therapy for diabetic nephropathy.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/rac-mgv354.html (Rac)-MGV354Cat. No.: HY-117917 HYPERLINK https:/www.M
10、edChemE/ataciguat.html Ataciguat(HMR-1766) Cat. No.: HY-17500(Rac)-MGV354 is the racemate of MGV354. MGV354 isa soluble guanylate cyclase (sGC) activator withEC s of 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK h
11、ttps:/www.MedChemE/cfm-1571-hydrochloride.html CFM HYPERLINK https:/www.MedChemE/cfm-1571-hydrochloride.html HYPERLINK https:/www.MedChemE/cfm-1571-hydrochloride.html 1571 HYPERLINK https:/www.MedChemE/cfm-1571-hydrochloride.html HYPERLINK https:/www.MedChemE/cfm-1571-hydrochloride.html hydrochlorid
12、e HYPERLINK https:/www.MedChemE/cfm-1571-hydrochloride.html HYPERLINK https:/www.MedChemE/Cinaciguat.html CinaciguatCat. No.: HY-107546(BAY 58-2667) Cat. No.: HY-14181CFM 1571 hydrochloride is the stimulator of thenitric oxide receptor, soluble guanylate cyclase(sGC) with an EC50 and IC50 of 5.49 M
13、and 2.84M, respectively. Soluble guanylate cyclase (sGC)is a key signal-transduction enzyme activated bynitric oxide (NO).Cinaciguat is an activator of guanylate cyclase(sGC), and used for acute decompensated heartfailure.Purity: 99.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 99
14、.20%Clinical Data: Phase 2Size: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/Cinaciguat-hydrochloride.html Cinaciguat HYPERLINK https:/www.MedChemE/Cinaciguat-hydrochloride.html HYPERLINK https:/www.MedChemE/Cinaciguat-h
15、ydrochloride.html hydrochloride(BAY 58-2667 hydrochloride) Cat. No.: HY-14181A HYPERLINK https:/www.MedChemE/ebselen-oxide.html Ebselen HYPERLINK https:/www.MedChemE/ebselen-oxide.html HYPERLINK https:/www.MedChemE/ebselen-oxide.html oxideCat. No.: HY-114548Cinaciguat hydrochloride is a potent solub
16、leguanylate cyclase (GC) activator with EC of 1550nM in platelets.Ebselen oxide, the selenone analogue of Ebselen,covalently modifies diguanylate cyclase (DGC) toinhibit c-di-GMP-receptor interactions and reducesDGC activity. Ebselen oxide also inhibits alginateproduction (IC =14 M) by50 Pseudomonas
17、aeruginosa.Purity: 99.52%Clinical Data: Phase 2Size: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/guanylate-cyclase-in-1.html Guanylate HYPERLINK https:/www.MedChemE/guanylate-cyclase-in-1.html HYPERLINK https:/ww
18、w.MedChemE/guanylate-cyclase-in-1.html cyclase-IN-1 HYPERLINK https:/www.MedChemE/guanylate-cyclase-in-1.html HYPERLINK https:/www.MedChemE/guanylin-human.html Guanylin(human)Cat. No.: HY-W021162 Cat. No.: HY-P1179Guanylate cyclase-IN-1 (Example 46) is a guanylatecyclase inhibitor that can be used f
19、orcardiovascular diseases research.Guanylin(human), a 15-amino acid peptide, is anendogenous intestinal guanylate cyclase activator.Purity: 99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/guany
20、lin-human-tfa.html Guanylin(human) HYPERLINK https:/www.MedChemE/guanylin-human-tfa.html HYPERLINK https:/www.MedChemE/guanylin-human-tfa.html TFACat. No.: HY-P1179A HYPERLINK https:/www.MedChemE/Lificiguat.html Lificiguat(YC-1) Cat. No.: HY-14927Guanylin(human) TFA, a 15-amino acid peptide, isan en
21、dogenous intestinal guanylate cyclaseactivator.Lificiguat binds to the subunit of solubleguanylyl cyclase(sGC) with K of 0.6-1.1 M indthe presence of CO.Purity: 97.45%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.48%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10
22、mg, 50 mg, 100 mg, 200 mg HYPERLINK https:/www.MedChemE/Linaclotide.html Linaclotide HYPERLINK https:/www.MedChemE/Linaclotide.html HYPERLINK https:/www.MedChemE/ly83583.html LY83583Cat. No.: HY-17584 Cat. No.: HY-W013386Linaclotide is a potent and selective guanylatecyclase C agonist; developed for
23、 the treatment ofconstipation-predominant irritable bowel syndrome(IBS-C) and chronic constipation.LY83583 is a cell-permeable and competitiveinhibitor of soluble guanylate cyclase (sGC) withan IC value of 2 M.50Purity: 98.44%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mgPurity: 98%Clinical Da
24、ta: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Methylene-Blue.html Methylene HYPERLINK https:/www.MedChemE/Methylene-Blue.html HYPERLINK https:/www.MedChemE/Methylene-Blue.html Blue HYPERLINK https:/www.MedChemE/Methylene-Blue.html HYPERLINK https:/www.MedChemE/methylene-b
25、lue-trihydrate.html Methylene HYPERLINK https:/www.MedChemE/methylene-blue-trihydrate.html HYPERLINK https:/www.MedChemE/methylene-blue-trihydrate.html blue HYPERLINK https:/www.MedChemE/methylene-blue-trihydrate.html HYPERLINK https:/www.MedChemE/methylene-blue-trihydrate.html trihydrate(Basic Blue
26、 9; CI-52015; Methylthioninium chloride) Cat. No.: HY-14536 (C.I. Basic Blue 9 trihydrate) Cat. No.: HY-B1359Methylene blue (Basic Blue 9) is a guanylyl cyclase(sGC), monoamine oxidase A (MAO-A) and NOsynthase (NOS) inhibitor. Methylene blue is avasopressor and is often used as a dye in severalmedic
27、al procedures.Methylene blue trihydrate (C.I. Basic Blue 9trihydrate) is a guanylyl cyclase (sGC),monoamine oxidase A (MAO-A) and NO synthase(NOS) inhibitor. Methylene blue trihydrate is avasopressor and is often used as a dye in severalmedical procedures.Purity: 98.0%Clinical Data: LaunchedSize: 10
28、0 mg, 500 mgPurity: 97.0%Clinical Data: LaunchedSize: 10 mM 1 mL, 100 mg, 500 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/sGC_activator_1.html MGV354 HYPERLINK https:/www.MedChemE/sGC_activator_1.html HYPERLINK https:/www.MedChemE/mm-419447.html MM HYPERLINK https:/www.MedChemE/mm-419447.html HYP
29、ERLINK https:/www.MedChemE/mm-419447.html 419447Cat. No.: HY-111516 Cat. No.: HY-P3282MGV354 is a soluble guanylate cyclase (sGC)activator with EC s of 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.40%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
30、, 10 mg HYPERLINK https:/www.MedChemE/mosliciguat.html MosliciguatCat. No.: HY-137446 HYPERLINK https:/www.MedChemE/Nelociguat.html Nelociguat(BAY60-4552) Cat. No.: HY-78237Mosliciguat is a guanylate cyclase activator.Nelociguat (BAY60-4552) is a nitric oxidesensitive soluble guanylate cyclase stimu
31、lator.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.73%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg, 200 mg HYPERLINK https:/www.MedChemE/ns-2028.html NS-2028 HYPERLINK https:/www.MedChemE/ns-2028.html HYPERLINK https:/www.MedChemE/odq.html ODQCat.
32、 No.: HY-12379 Cat. No.: HY-101255NS-2028 is a highly selective soluble GuanylylCyclase (sGC) inhibitor with IC values of 30 nM50and 200 nM for basal and NO-stimulated enzymeactivity.ODQ is a potent and selective soluble guanylylcyclase (sGC, nitric oxide-activated enzyme)inhibitor. ODQ enhances the
33、 pro-apoptotic effectsof Cisplatin in human mesothelioma cells.Purity: 99.91%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.52%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/olinciguat.html Olinc
34、iguat HYPERLINK https:/www.MedChemE/olinciguat.html HYPERLINK https:/www.MedChemE/plecanatide.html Plecanatide(IW-1701) Cat. No.: HY-109066Cat. No.: HY-108741Olinciguat (IW-1701) is an oral guanylate cyclase(sGC) stimulator with concentration-dependentstimulation of sGC in purified rat and humanenzy
35、me assays and a whole cell assay.Plecanatide, an analogue of Uroguanylin, is anorally active guanylate cyclase-C (GC-C) receptoragonist. Plecanatide activates GC-C receptors tostimulate cGMP synthesis with an EC of 190 nM50in T84 cells assay.Purity: 98.44%Clinical Data: No Development ReportedSize:
36、5 mg, 10 mg, 50 mg, 100 mgPurity: 98.90%Clinical Data: LaunchedSize: 5 mg, 10 mg HYPERLINK https:/www.MedChemE/Plecanatide_acetate.html Plecanatide HYPERLINK https:/www.MedChemE/Plecanatide_acetate.html HYPERLINK https:/www.MedChemE/Plecanatide_acetate.html acetate HYPERLINK https:/www.MedChemE/Plec
37、anatide_acetate.html HYPERLINK https:/www.MedChemE/praliciguat.html PraliciguatCat. No.: HY-108741A(IW-1973) Cat. No.: HY-109039Plecanatide acetate, an analogue of Uroguanylin,is an orally active guanylate cyclase-C (GC-C)receptor agonist. Plecanatide acetate activatesGC-C receptors to stimulate cGM
38、P synthesis with anEC of 190 nM in T84 cells assay.50Praliciguat (IW-1973) is a potent and orallyactive soluble guanylate cyclase stimulator,enhances NO signaling, acts as a vasodilator.Praliciguat (IW-1973) stimulates sGC in HEK-293cells with an EC of 197 nM.50Purity: 99.26%Clinical Data: LaunchedS
39、ize: 5 mg, 10 mgPurity: 98.79%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/Riociguat.html Riociguat(BAY 632521) Cat. No.: HY-14779 HYPERLINK https:/www.MedChemE/riociguat-13c
40、-d3.html Riociguat-13C-d3(BAY 632521-13C-d3) Cat. No.: HY-14779S2Riociguat is an oral stimulator of solubleguanylate cyclase (sGC) used in the treatment ofpulmonary hypertension.Riociguat-13C-d3 (BAY 632521-13C-d3) is the 13C-and deuterium labeled Riociguat. Riociguat is anoral stimulator of soluble guanylate cyclase(sGC) used in the treatment of pulmonaryhypertension.Purity: 99.58%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg, 200 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/riocig
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年綜合性干果采購合同
- 2024年舞蹈教室場地租賃服務合同范本3篇
- 2024年版?zhèn)€人汽車租賃協(xié)議模板一
- 煙草崗位培訓課程設計
- 2024年房產(chǎn)交易合同范例
- 2024年度音響設備租賃與舞臺劇制作服務合同3篇
- 2024-2025學年人教新版九年級(上)化學寒假作業(yè)(二)
- 2024年度體育產(chǎn)業(yè)員工試用期勞動合同模板3篇
- 2024年汽車租賃與景區(qū)門票優(yōu)惠合作協(xié)議范本3篇
- 數(shù)碼顯示鐘課程設計
- 錨索張拉伸長量計算
- 部編版語文九年級上冊單元復習課教案
- 孕酮檢驗報告
- 2024年度醫(yī)院皮膚科醫(yī)務人員績效述職統(tǒng)計報告課件
- 《成本費用控制》課件
- 醫(yī)院消防培訓方案
- 【人教部編版語文六年級上冊】選擇題專項練習復習(100道題后附答案)
- 外科醫(yī)學教學設計
- 創(chuàng)辦臺球廳的計劃書
- 廣東省廣州市越秀區(qū)2022-2023學年八年級上學期期末物理試卷
- 統(tǒng)編版語文四年級上冊《期末作文專項復習》 課件
評論
0/150
提交評論